A daily pill developed by the US pharmaceutical company Lilly may become a convenient alternative to injectable drugs like ...

But this doesn't negate the drugs' potential downsides, one of which has doctors urging patients to "proceed with caution" ...

New research suggests that GLP-1 drugs like Ozempic and Wegovy, commonly used for diabetes and weight loss, may also reduce the risk of Alzheimer's disease and dementia.

The studies also ‘offer hope’ that transplanted cells could tackle symptoms of the condition, such as tremors.

Other weight loss drugs must be injected, meaning the new pill from pharmaceutical giant Eli Lilly could become patients’ top ...

In November, Mr. Biden set out to change that with a new rule that would drastically expand access to this type of medication ...

Dr. Daniel Drucker shares the US$3 million prize with four colleagues in the U.S. and Denmark for discovering the GLP-1 ...

Dr. Daniel Drucker, an endocrinologist and a clinician-scientist at the University of Toronto and the Lunenfeld-Tanenbaum ...

Robbie Williams has revealed he was diagnosed with scurvy after rapid weight loss caused by taking an appetite suppressant — ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

A new study into GLP-1RA drugs provides previously unknown insights into the impact this class of drugs may have on eating ...

Officials for the Centers for Disease Control and Prevention denied Milwaukee Public Schools officials' request for help with ...